Guest Column: Understanding AdvaMed's ‘Library Of Successful Quality Practices’
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed’s Sharon Segal introduces the device industry group’s new “Library of Successful Quality Practices,” a resource for manufacturers to enhance their own quality processes.
You may also be interested in...
Survey Finds 1/3 Of Device Firms Don't Measure The Cost Of Quality. Here's How A Case For Quality Initiative Might Help
A recent device industry survey shows that 33% of manufacturers are likely wasting money on quality efforts that are ineffective because they're not calculating the cost of quality. The survey comes under the auspices of a Case for Quality workgroup that is looking for best ways to engage leadership at device firms in quality activities. The group says it will use the survey results to inform its work as it pens a playbook of best practices for engaging leaders that will, among other things, stress the importance of knowing the cost of quality.
New 'Quality Culture Playbook' Aims To Drive An Organization-Wide Quality Mindset, AdvaMed Says
The device industry advocacy group is putting the final touches on its free playbook, which draws from proven quality culture work conducted at high-profile companies like Medtronic and Covidien, among others.
Root Cause Analysis A Key Element Of FDA’s ‘Case For Quality’
CDRH is highlighting poor root cause analysis as part of its “Case for Quality,” an initiative that encourages companies to make quality assurance an organization-wide concern. Since FDA directed firms in 2009 to write FDA-483 response letters within 15 workdays after an inspection, the agency has been concerned that companies might feel compelled to fix every citation listed on the inspection form quickly without considering root causes. “What we are worried about is that this perceived need to respond in such a manner may prevent firms from taking time for a greater root cause assessment of the systemic problems that gave rise to the FDA-483 citations,” CDRH Office of Compliance Director Steven Silverman said. The Case for Quality will also examine how companies are inspected and how to make device quality data more accessible to firms.